Saratikov A S, Litvinenko Iu A, Burkova V N, Vengerovskiĭ A I, Chuchalin V S
Pharmacology Department, Siberian Medical University, Moskovskii trakt 2, Tomsk, 634050 Russia.
Eksp Klin Farmakol. 2002 Mar-Apr;65(2):31-3.
The experiments on rats with a model toxic liver damage (tetrachloromethane hepatitis) showed evidence of a high hepatoprotector activity of liproxol, representing a combination of eplir and lokhein mixed in a 1-12 ratio. Liproxol inhibits lipid peroxidation, stimulates the excretory and detoxicant functions of liver, reduces hyperfermentation, and normalized membrane phospholipid composition.